Oncology and Hematology
Oncology and Hematology Clinical Practice
Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.
Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.
Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.
106-120 of 298
Sagar Lonial, MD, FACP
Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
MinuteCE®Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
Joshua Richter, MD
Sagar Lonial, MD, FACP
Case Application: Frontline Insights—Tackling Newly Diagnosed Myeloma
MinuteCE®Case Application: Frontline Insights—Tackling Newly Diagnosed Myeloma
Joshua Richter, MD
Noopur Raje, MD
Next-Generation Innovations: The Future of CELMoDs in Myeloma
MinuteCE®Next-Generation Innovations: The Future of CELMoDs in Myeloma
Noopur Raje, MD
Emerging Therapeutic Developments in Non-Targetable Metastatic NSCLC
MinuteCE®Emerging Therapeutic Developments in Non-Targetable Metastatic NSCLC
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
John M. Kirkwood, MD
Paolo A. Ascierto, MD
Hussein Tawbi, MD, PhD
Sapna Patel, MD
- advertisement
The Current Therapeutic Landscape in Unresectable Stage III NSCLC
MinuteCE®The Current Therapeutic Landscape in Unresectable Stage III NSCLC
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
MinuteCE®Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
Hussein Tawbi, MD, PhD
Sapna Patel, MD
MET and Other Emerging Targets in Metastatic NSCLC
MinuteCE®MET and Other Emerging Targets in Metastatic NSCLC
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
MinuteCE®Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
John M. Kirkwood, MD
Sapna Patel, MD
Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC
MinuteCE®Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
MinuteCE®Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
- advertisement
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
MinuteCE®Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
Paolo A. Ascierto, MD
Hussein Tawbi, MD, PhD
Applications of Emerging Data in Resectable NSCLC
MinuteCE®Applications of Emerging Data in Resectable NSCLC
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
